Please enable JavaScript in your browser. 
Skip to main content
Drug Information Portal National Library of Medicine
Home
 
       Home    Substance
     
Result
PropertyValue
Drug Name: Canvaxin
Description: A polyvalent vaccine immunotherapy for melanoma of three viable irradiated melanoma cell lines which contain at least 11 known tumor-associated antigens such as MAGE-1, MAGE-3, tyrosinase, gp100, gp75, and Mart-1/Melan-A; increased IgM response in patients receiving vaccine therapy for stage II melanoma was associated with decreased recurrence and improved survival. 



 
 
Site Map, Contact Us, Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services
Freedom of Information Act
Drug Information Portal Mobile Site
Last updated: Sep 2017
USA.gov